CytomX Therapeutics, Inc. (CTMX)

CytomX Therapeutics Revenue

CytomX Therapeutics had revenue of $33.43M in the quarter ending September 30, 2024, with 26.71% growth. This brings the company's revenue in the last twelve months to $126.62M, up 33.66% year-over-year. In the year 2023, CytomX Therapeutics had annual revenue of $101.21M with 90.38% growth.

• Revenue (ttm): $126.62M
• Revenue Growth: +33.66%
• P/S Ratio: 0.57
• Revenue / Employee: $1,037,844
• Employees: 122
• Market Cap: 66.61M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	101.21M	48.05M	90.38%
Dec 31, 2022	53.16M	15.85M	42.48%
Dec 31, 2021	37.31M	-31.12M	-45.47%
Dec 31, 2020	68.43M	41.53M	154.36%
Dec 31, 2019	26.90M	-32.60M	-54.79%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.